CSL Behring - UK Homepage

Global Home |Contact Us |Site Map |eNews Signup

CSL Behring is a global leader in plasma protein biotherapeutics. The company is committed to improving the quality of life for people with rare and serious diseases such as haemophilia, von Willebrand disease, immune deficiency disorders and hereditary angiodema. Our therapies are also used for rapid warfarin reversal and to prevent haemolytic disease of the newborn.

1 Nov 2011
CSL Behring seeks proposals for Interlaken Leadership Awards, supporting innovative research into neuroimmunology

1 April 2011
CSL Behring UK launches Riastap^®, the first and only licensed fibrinogen concentrate in the UK

Video


The Mix2Vial^® is a device for the reconstruction of CSL Behring manufactured freeze-dried products

Biotherapies for Life